References
- Prince M , WimoA, GuerchetM, AliG-C, WuY-T, PrinaM. World Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends (2015).https://www.alz.co.uk/research/world-report-2015.
- Fernandez M , GobarttAL, BalanaM, GroupCS. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol.10, 87 (2010).
- Marsh SE , AbudEM, LakatosAet al. The adaptive immune system restrains Alzheimer's disease pathogenesis by modulating microglial function. Proc. Natl Acad. Sci. USA113(9), E1316–E1325 (2016).
- Blasko I , Stampfer-KountchevM, RobatscherP, VeerhuisR, EikelenboomP, Grubeck-LoebensteinB. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell3(4), 169–176 (2004).
- Lull ME , BlockML. Microglial activation and chronic neurodegeneration. Neurotherapeutics7(4), 354–365 (2010).
- Jessen KR . Glial cells. Int. J. Biochem. Cell Biol.36(10), 1861–1867 (2004).
- Von Bernhardi R , CornejoF, ParadaGE, EugeninJ. Role of TGFbeta signaling in the pathogenesis of Alzheimer's disease. Front. Cell Neurosci.9, 426 (2015).
- Luo XG , ChenSD. The changing phenotype of microglia from homeostasis to disease. Transl. Neurodegener.1(1), 9 (2012).
- Boche D , PerryVH, NicollJA. Review: activation patterns of microglia and their identification in the human brain. Neuropathol. Appl. Neurobiol.39(1), 3–18 (2013).
- Block ML , ZeccaL, HongJS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci.8(1), 57–69 (2007).
- Venigalla M , SonegoS, GyengesiE, SharmanMJ, MunchG. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. Neurochem. Int.95, 63–74 (2016).
- Sokolova A , HillMD, RahimiF, WardenLA, HallidayGM, ShepherdCE. Monocyte chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease. Brain Pathol.19(3), 392–398 (2009).
- Kamphuis W , MamberC, MoetonMet al. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS ONE7(8), e42823 (2012).
- Rao JS , RapoportSI, KimHW. Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain. Transl. Psychiatry1, e31 (2011).
- Miguel-Alvarez M , Santos-LozanoA, Sanchis-GomarFet al. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect. Drugs Aging32(2), 139–147 (2015).
- Wang J , TanL, WangHFet al. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. J. Alzheimers Dis.44(2), 385–396 (2015).
- Chen J , GuanZ, WangL, SongG, MaB, WangY. Meta-analysis: overweight, obesity, and Parkinson's disease. Int. J. Endocrinol.2014, 203930 (2014).
- Viticchi G , FalsettiL, BurattiLet al. Metabolic syndrome and cerebrovascular impairment in Alzheimer's disease. Int. J. Geriatr. Psychiatry30(12), 1164–1170 (2015).
- Ríos JA , CisternasP, ArreseM, BarjaS, InestrosaNC. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. Prog. Neurobiol.121, 125–146 (2014).
- Codocedo JF , RiosJA, GodoyJA, InestrosaNC. Are microRNAs the molecular link between metabolic syndrome and Alzheimer's disease?Mol. Neurobiol.53(4), 2320–2338 (2016).
- Barnes DE , YaffeK. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol.10(9), 819–828 (2011).
- Whitmer RA , GundersonEP, QuesenberryCPJr, ZhouJ, YaffeK. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr. Alzheimer Res.4(2), 103–109 (2007).
- Costanzo P , ClelandJG, PellicoriPet al. The obesity paradox in Type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann. Intern. Med.162(9), 610–618 (2015).
- Spielman LJ , LittleJP, KlegerisA. Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res. Bull.125, 19–29 (2016).
- Spielman LJ , LittleJP, KlegerisA. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration. J. Neuroimmunol.273(1–2), 8–21 (2014).
- Brundage SI , KirilcukNN, LamJC, SpainDA, ZautkeNA. Insulin increases the release of proinflammatory mediators. J. Trauma65(2), 367–372 (2008).
- De Felice FG , FerreiraST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting Type 2 diabetes to Alzheimer disease. Diabetes63(7), 2262–2272 (2014).
- Kawanishi N , YanoH, YokogawaY, SuzukiK. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc. Immunol. Rev.16, 105–118 (2010).
- Reyna SM , GhoshS, TantiwongPet al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes57(10), 2595–2602 (2008).
- Lobato NS , FilgueiraFP, AkamineEH, TostesRC, CarvalhoMH, FortesZB. Mechanisms of endothelial dysfunction in obesity-associated hypertension. Braz. J. Med. Biol. Res.45(5), 392–400 (2012).
- Yang F , WangZ, ZhangJHet al. Receptor for advanced glycation end-product antagonist reduces blood–brain barrier damage after intracerebral hemorrhage. Stroke46(5), 1328–1336 (2015).
- Little JP , MadeiraJM, KlegerisA. The saturated fatty acid palmitate induces human monocytic cell toxicity toward neuronal cells: exploring a possible link between obesity-related metabolic impairments and neuroinflammation. J. Alzheimers Dis.30(Suppl. 2), S179–S183 (2012).
- Thirumangalakudi L , PrakasamA, ZhangRet al. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J. Neurochem.106(1), 475–485 (2008).
- Drake C , BoutinH, JonesMSet al. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav. Immun.25(6), 1113–1122 (2011).
- Zhang X , ZhangG, ZhangH, KarinM, BaiH, CaiD. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell135(1), 61–73 (2008).
- Thaler JP , YiCX, SchurEAet al. Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest.122(1), 153–162 (2012).
- Dey A , HaoS, ErionJR, Wosiski-KuhnM, StranahanAM. Glucocorticoid sensitization of microglia in a genetic mouse model of obesity and diabetes. J. Neuroimmunol.269(1–2), 20–27 (2014).
- Parthsarathy V , HolscherC. The Type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain. Eur. J. Pharmacol.700(1–3), 42–50 (2013).
- Bai J , WeiP, ZhaoNet al. A study of mild cognitive impairment in veterans: role of hypertension and other confounding factors. Neuropsychol. Dev. Cogn. B. Aging Neuropsychol. Cogn.23(6), 703–715 (2016).
- Makridakis S , DinicolantonioJJ. Hypertension: empirical evidence and implications in 2014. Open Heart1(1), e000048 (2014).
- Dinh QN , DrummondGR, SobeyCG, ChrissobolisS. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed. Res. Int.2014, 406960 (2014).
- Jennings JR , MuldoonMF, RyanCet al. Reduced cerebral blood flow response and compensation among patients with untreated hypertension. Neuology64(8), 1358–1365 (2005).
- Jones JD , JacobsonC, MurphyM, PriceC, OkunMS, BowersD. Influence of hypertension on neurocognitive domains in nondemented Parkinson's disease patients. Parkinsons Dis.2014, 507529 (2014).
- Carnevale D , MascioG, Ajmone-CatMAet al. Role of neuroinflammation in hypertension-induced brain amyloid pathology. Neurobiol. Aging33(1), 205.e19–205.e29 (2012).
- Tang JP , RakhitA, DouglasFL, MelethilS. Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril. Pharm. Res.9(2), 236–243 (1992).
- Tayebati SK , TomassoniD, AmentaF. Neuroinflammatory markers in spontaneously hypertensive rat brain: an immunohistochemical study. CNS Neurol. Disord. Drug Targets doi:10.2174/1871527315666160527155014 (2016) ( Epub ahead of print).
- Nishioku T , MatsumotoJ, DohguSet al. Tumor necrosis factor-alpha mediates the blood–brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J. Pharmacol. Sci.112(2), 251–254 (2010).
- Wang LY , TuYF, LinYC, HuangCC. CXCL5 signaling is a shared pathway of neuroinflammation and blood–brain barrier injury contributing to white matter injury in the immature brain. J. Neuroinflammation13, 6 (2016).
- Kruyer A , SoplopN, StricklandS, NorrisEH. Chronic hypertension leads to neurodegeneration in the TgSwDI mouse model of Alzheimer's disease. Hypertension66(1), 175–182 (2015).
- Caspersen CJ , PowellKE, ChristensonGM. Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep.100(2), 126–131 (1985).
- Chen J , MillarWJ. Health effects of physical activity. Health Rep.11(1), 21–30 (Eng); 21–31 (Fre) (1999).
- Maliszewska-Cyna E , XhimaK, AubertI. A comparative study evaluating the impact of physical exercise on disease progression in a mouse model of Alzheimer's disease. J. Alzheimers Dis.53(1), 243–57 (2016).
- Tapia-Rojas C , AranguizF, Varela-NallarL, InestrosaNC. Voluntary running attenuates memory loss, decreases neuropathological changes and induces neurogenesis in a mouse model of Alzheimer's disease. Brain Pathol.26(1), 62–74 (2016).
- Campos C , RochaNB, LattariE, PaesF, NardiAE, MachadoS. Exercise-induced neuroprotective effects on neurodegenerative diseases: the key role of trophic factors. Expert Rev. Neurother.16(6), 723–734 (2016).
- Szuhany KL , BugattiM, OttoMW. A meta-analytic review of the effects of exercise on brain-derived neurotrophic factor. J. Psychiatr. Res.60, 56–64 (2015).
- Kohman RA , DeyoungEK, BhattacharyaTK, PetersonLN, RhodesJS. Wheel running attenuates microglia proliferation and increases expression of a proneurogenic phenotype in the hippocampus of aged mice. Brain Behav. Immun.26(5), 803–810 (2012).
- Fleshner M , GreenwoodBN, YirmiyaR. Neuronal–glial mechanisms of exercise-evoked stress robustness. Curr. Top. Behav. Neurosci.18, 1–12 (2014).
- Scarmeas N , LuchsingerJA, SchupfNet al. Physical activity, diet, and risk of Alzheimer disease. JAMA302(6), 627–637 (2009).
- Smith PJ , BlumenthalJA, HoffmanBMet al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom. Med.72(3), 239–252 (2010).